Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase

被引:37
|
作者
Ueki, Iori [1 ]
Roman, Heather B. [1 ]
Hirschberger, Lawrence L. [1 ]
Junior, Carolyn [1 ]
Stipanuk, Martha H. [1 ]
机构
[1] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA
关键词
sulfur amino acids; sulfate; glutathione; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; CYSTATHIONINE BETA-SYNTHASE; SULFUR AMINO-ACIDS; INTRACELLULAR CYSTEINE; PROTEASOME SYSTEM; METABOLISM; ENZYMES; GLUTATHIONE; PROTEIN; DECARBOXYLASE;
D O I
10.1152/ajpendo.00589.2011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ueki I, Roman HB, Hirschberger LL, Junior C, Stipanuk MH. Extrahepatic tissues compensate for loss of hepatic taurine synthesis in mice with liver-specific knockout of cysteine dioxygenase. Am J Physiol Endocrinol Metab 302: E1292-E1299, 2012. First published March 13, 2012; doi:10.1152/ajpendo.00589.2011.-Because hepatic cysteine dioxygenase (CDO) appears to play the major role in controlling cysteine catabolism in the intact rat, we characterized the effect of a lack of hepatic CDO on the regulation of cysteine and its metabolites at the whole body level. In mice with liver-specific deletion of CDO expression, hepatic and plasma cysteine levels increased. In addition, in mice with liver-specific deletion of CDO expression, the abundance of CDO and the proportion of CDO existing as the mature, more active isoform increased in extrahepatic tissues that express CDO (kidney, brown fat, and gonadal fat). CDO abundance was also increased in the pancreas, where most of the enzyme in both control and liver CDO-knockout mice was in the more active isoform. This upregulation of CDO concentration and active-site cofactor formation were not associated with an increase in CDO mRNA and thus presumably were due to a decrease in CDO degradation and an increase in CDO cofactor formation in association with increased exposure of extrahepatic tissues to cysteine in mice lacking hepatic CDO. Extrahepatic tissues of liver CDO-knockout mice also had higher levels of hypotaurine, consistent with increased metabolism of cysteine by the CDO/cysteinesulfinate decarboxylase pathway. The hepatic CDO-knockout mice were able to maintain normal levels of glutathione, taurine, and sulfate. The maintenance of taurine concentrations in liver as well as in extrahepatic tissues is particularly notable, since mice were fed a taurine-free diet and liver is normally considered the major site of taurine biosynthesis. This redundant capacity for regulation of cysteine concentrations and production of hypotaurine/taurine is additional support for the body's robust mechanisms for control of body cysteine levels and indicates that extrahepatic tissues are able to compensate for a lack of hepatic capacity for cysteine catabolism.
引用
收藏
页码:E1292 / E1299
页数:8
相关论文
共 50 条
  • [21] Liver-Specific Loss of Perilipin 2 Alleviates Hepatic Steatosis and Inflammation
    Atshaves, Barbara
    Aljazi, Mohammad
    Olenic, Sandra
    Fader, Kelly
    Najt, Charles
    FASEB JOURNAL, 2015, 29
  • [22] Stability and reproducibility assessment of liver-specific GK gene knockout mice and the role of hepatic GK in the pathogenesis of diabetes mellitus
    Mao, Yiqing
    Xiao, Meifang
    Zhang, Yali
    Zhang, Xuemei
    Zhao, Shuyong
    Li, Hui
    Niu, Gang
    Tan, Huanran
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 302 - 302
  • [23] Generation and characterisation of liver-specific Jagged2 knockout mice for liver cancer research
    Nguyen, Romario
    Bae, Sarah
    Qiao, Liang
    George, Jacob
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 50 - 50
  • [24] Liver-specific deletion of TSHR inhibits hepatic lipid accumulation in mice
    Zhou, Lingyan
    Wu, Kunpeng
    Zhang, Liya
    Gao, Ling
    Chen, Shihong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (01) : 39 - 45
  • [25] Mechanisms by which liver-specific PEPCK knockout mice preserve euglycemia during starvation
    She, PX
    Burgess, SC
    Shiota, M
    Flakoll, P
    Donahue, EP
    Malloy, CR
    Sherry, AD
    Magnuson, MA
    DIABETES, 2003, 52 (07) : 1649 - 1654
  • [26] Phenotypic differences between brain- and liver-specific glutamine synthetase knockout mice
    Hu, Q. X.
    Eid, T.
    Danbolt, N. C.
    Zhou, Y.
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 220 - 220
  • [27] Liver-specific PDK1 knockout mice are insulin resistant and glucose intolerant
    Nishizawa, A
    Ogawa, W
    Sakaue, H
    Teshigawara, K
    Furukawa, K
    Matsumoto, M
    Inoue, H
    Noda, T
    Kasuga, M
    DIABETES, 2003, 52 : A69 - A69
  • [28] Fatty Liver and Insulin Resistance in the Liver-Specific Knockout Mice of Mitogen Inducible Gene-6
    Park, Byung Kil
    Lee, Eun-Ah
    Kim, Hee-Youn
    Lee, Jun Choul
    Kim, Koon Soon
    Jeong, Won Hoon
    Kim, Ki Young
    Ku, Bon Jeong
    Rhee, Sang Dal
    JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [29] Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice
    Wang, Rong
    Gao, Hui
    Xu, Wei
    Li, Hui
    Mao, Yiqing
    Wang, Yi
    Guo, Tingting
    Wang, Xi
    Song, Rongjing
    Li, Zhixin
    Irwin, David M.
    Niu, Gang
    Tan, Huanran
    GENE, 2013, 516 (02) : 248 - 254
  • [30] Liver-specific glucocorticoid action in alcoholic liver disease: Study of glucocorticoid receptor knockout and knockin mice
    Wang, Yazheng
    Fahy, Conor
    Lu, Hong
    LIVER RESEARCH, 2024, 8 (02) : 91 - 104